Evidence map›Paper›PMID 22377231›Full record

ArticleEmerging infectious diseases2012

Community-associated Clostridium difficile infections, Monroe County, New York, USA.

Ghinwa Dumyati, Vanessa Stevens, George E Hannett, Angela D Thompson, Cherie Long, Duncan Maccannell, Brandi Limbago

Abstract read
In one paragraph

Article in Emerging infectious diseases, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Synergistic Antimicrobial Activity of Ceftriaxone andAntibiotics (Basel, Switzerland) · 2023
    Article
  2. Characterization of community-acquiredFrontiers in microbiology · 2023
    Article
  3. Transmission Dynamics of Clostridioides difficile in 2 High-Acuity Hospital Units.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Article
  4. Article
  5. Article
  6. Genomic Delineation of Zoonotic Origins ofFrontiers in public health · 2019
    Review
  7. Reducing risk ofTherapeutic advances in urology · 2018
    Article
  8. Risk Factors for Community-AssociatedOpen forum infectious diseases · 2017
    Article
  9. Clostridium difficile Infection.Microbiology spectrum · 2016
    Review
  10. Observational
  11. Article
  12. Article
  13. Impact of clinical awareness and diagnostic tests on the underdiagnosis of Clostridium difficile infection.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2015
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Epidemiology of Clostridium difficile infection.Journal of pharmacy practice · 2013
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ghinwa DumyatiCommunity Health, University of Rochester, Rochester, NY 14607, USA. ghinwa_dumyati@urmc.rochester.edu
Vanessa Stevens
George E Hannett
Angela D Thompson
Cherie Long
Duncan Maccannell
Brandi Limbago

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We conducted active sentinel surveillance in Monroe County, New York, USA, to compare incidence of community-associated Clostridium difficile infections (CA-CDIs) with that of health care-associated infections (HA-CDIs) and identify exposure and strain type differences between CA and HA cases. Patients positive for C. difficile toxin and with no documented health care exposure in the previous 12 weeks were defined as possible CA case-patients. Patients with onset in a health care setting or recent health care exposure were defined as HA case-patients. Eighteen percent of CDIs were CA; 76% were in persons who reported antimicrobial drug use in the 12 weeks before CDI diagnosis. Strain type distribution was similar between CA and HA cases; North American pulsed-field 1 was the primary strain (31% CA, 42% HA; p = 0.34). CA-CDI is an emergent disease affecting patients recently exposed to antimicrobial drugs. Community strains are similar to those found in health care settings.

Indexed as

AdultAgedClostridioides difficileCommunity-Acquired InfectionsCross InfectionEnterocolitis, PseudomembranousHumansIncidenceMicrobial Sensitivity TestsMiddle AgedNew YorkSentinel Surveillance

Identifiers

PMID22377231
PMCPMC3309637

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.